1. Home
  2. KMDA vs TBRG Comparison

KMDA vs TBRG Comparison

Compare KMDA & TBRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KMDA
  • TBRG
  • Stock Information
  • Founded
  • KMDA 1990
  • TBRG 1979
  • Country
  • KMDA Israel
  • TBRG United States
  • Employees
  • KMDA N/A
  • TBRG N/A
  • Industry
  • KMDA Biotechnology: Pharmaceutical Preparations
  • TBRG
  • Sector
  • KMDA Health Care
  • TBRG
  • Exchange
  • KMDA Nasdaq
  • TBRG NYSE
  • Market Cap
  • KMDA 399.7M
  • TBRG 393.0M
  • IPO Year
  • KMDA N/A
  • TBRG N/A
  • Fundamental
  • Price
  • KMDA $6.85
  • TBRG $23.82
  • Analyst Decision
  • KMDA Strong Buy
  • TBRG Buy
  • Analyst Count
  • KMDA 3
  • TBRG 3
  • Target Price
  • KMDA $14.67
  • TBRG $23.67
  • AVG Volume (30 Days)
  • KMDA 80.5K
  • TBRG 154.1K
  • Earning Date
  • KMDA 05-14-2025
  • TBRG 05-07-2025
  • Dividend Yield
  • KMDA 2.92%
  • TBRG N/A
  • EPS Growth
  • KMDA 31.21
  • TBRG N/A
  • EPS
  • KMDA 0.28
  • TBRG N/A
  • Revenue
  • KMDA $167,235,000.00
  • TBRG $345,737,000.00
  • Revenue This Year
  • KMDA $14.51
  • TBRG $5.15
  • Revenue Next Year
  • KMDA $9.31
  • TBRG $5.25
  • P/E Ratio
  • KMDA $23.98
  • TBRG N/A
  • Revenue Growth
  • KMDA 11.83
  • TBRG 3.56
  • 52 Week Low
  • KMDA $4.74
  • TBRG $9.33
  • 52 Week High
  • KMDA $9.16
  • TBRG $32.00
  • Technical
  • Relative Strength Index (RSI)
  • KMDA 52.85
  • TBRG 42.03
  • Support Level
  • KMDA $6.64
  • TBRG $23.38
  • Resistance Level
  • KMDA $6.99
  • TBRG $24.90
  • Average True Range (ATR)
  • KMDA 0.17
  • TBRG 0.79
  • MACD
  • KMDA -0.02
  • TBRG -0.01
  • Stochastic Oscillator
  • KMDA 58.00
  • TBRG 34.60

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

About TBRG TRUBRIDGE INC

TruBridge Inc is a provider of healthcare solutions and services for community hospitals, clinics, and other healthcare systems. It provides services such as Electronic health records & information systems, revenue cycle management, population health, and data management, etc. The segments of the company are Revenue Cycle Management (RCM), (ii) Electronic Health Records (EHR), and (iii) Patient Engagement The company derives maximum revenue from the RCM segment.

Share on Social Networks: